Shionogi & (4507.T) Financial Statements
Price: $2334.5
Market Cap: $1.99T
Avg Volume: 2.33M
Market Cap: $1.99T
Avg Volume: 2.33M
Country: JP
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Shionogi & .
Income Statement
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $435.08B | $426.68B | $335.14B | $297.18B | $333.37B | $363.72B | $344.67B | $338.89B | $309.97B | $273.99B |
| Cost of Revenue | $66.00B | $62.25B | $55.41B | $52.52B | $56.78B | $54.88B | $73.91B | $77.78B | $74.76B | $82.19B |
| Gross Profit | $369.09B | $364.44B | $279.72B | $244.65B | $276.59B | $308.84B | $270.76B | $261.11B | $235.22B | $191.80B |
| Gross Profit Ratio | 84.83% | 85.41% | 83.47% | 82.33% | 82.97% | 84.91% | 78.56% | 77.05% | 75.88% | 70.00% |
| Research and Development Expenses | $102.64B | $102.39B | $73.00B | $54.25B | $47.95B | $68.33B | $59.95B | $59.91B | $49.79B | $48.87B |
| General and Administrative Expenses | $81.08B | $97.78B | $91.77B | $91.90B | $95.09B | $85.22B | $80.78B | $78.18B | $75.99B | $75.65B |
| Selling and Marketing Expenses | $13.91B | $7.52B | $9.98B | $13.04B | $15.41B | $16.76B | $14.81B | $14.85B | $18.03B | $16.91B |
| Selling General and Administrative Expenses | $94.99B | $97.78B | $91.77B | $91.90B | $95.09B | $101.98B | $95.59B | $93.03B | $94.02B | $92.57B |
| Other Expenses | $- | $- | $4.64B | $-18.94B | $-1.30B | $-1.13B | $-1.14B | $-1.16B | $-1.07B | $-1.11B |
| Operating Expenses | $197.63B | $215.43B | $169.41B | $127.21B | $145.96B | $170.30B | $155.54B | $152.93B | $143.81B | $141.44B |
| Cost and Expenses | $263.62B | $277.68B | $224.82B | $179.74B | $202.74B | $225.18B | $229.45B | $230.71B | $218.57B | $223.62B |
| Interest Income | $51.67B | $75.83B | $16.80B | $26.52B | $30.50B | $2.39B | $1.17B | $808.00M | $774.00M | $500.00M |
| Interest Expense | $6.70B | $4.50B | $841.00M | $941.00M | $2.62B | $581.00M | $557.00M | $220.00M | $207.00M | $274.00M |
| Depreciation and Amortization | $18.32B | $17.16B | $16.29B | $14.71B | $14.04B | $18.70B | $19.01B | $16.34B | $15.87B | $15.65B |
| EBITDA | $217.81B | $176.41B | $143.42B | $158.67B | $174.47B | $194.70B | $134.23B | $124.52B | $107.28B | $66.02B |
| EBITDA Ratio | 50.06% | 41.35% | 42.80% | 53.39% | 52.34% | 53.53% | 38.94% | 36.74% | 34.61% | 24.09% |
| Operating Income | $171.46B | $149.00B | $110.31B | $117.44B | $130.63B | $138.54B | $115.22B | $108.18B | $91.41B | $50.37B |
| Operating Income Ratio | 39.41% | 34.92% | 32.92% | 39.52% | 39.18% | 38.09% | 33.43% | 31.92% | 29.49% | 18.38% |
| Total Other Income Expenses Net | $26.82B | $59.78B | $15.96B | $25.58B | $27.89B | $1.97B | $22.16B | $14.52B | $6.05B | $31.69B |
| Income Before Tax | $198.28B | $220.33B | $126.27B | $143.02B | $158.52B | $170.34B | $137.38B | $122.69B | $97.45B | $82.05B |
| Income Before Tax Ratio | 45.57% | 51.64% | 37.68% | 48.13% | 47.55% | 46.83% | 39.86% | 36.20% | 31.44% | 29.95% |
| Income Tax Expense | $37.71B | $35.84B | $12.83B | $30.96B | $36.32B | $37.04B | $28.59B | $39.08B | $30.82B | $37.83B |
| Net Income | $162.03B | $184.97B | $114.19B | $111.86B | $122.19B | $132.76B | $108.87B | $83.88B | $66.69B | $44.06B |
| Net Income Ratio | 37.24% | 43.35% | 34.07% | 37.64% | 36.65% | 36.50% | 31.59% | 24.75% | 21.51% | 16.08% |
| EPS | $186.17 | $206.90 | $126.12 | $121.55 | $131.77 | $141.30 | $114.12 | $86.54 | $68.21 | $44.18 |
| EPS Diluted | $558.32 | $206.82 | $126.08 | $121.51 | $131.63 | $140.09 | $112.36 | $85.20 | $67.17 | $43.97 |
| Weighted Average Shares Outstanding | 870.33M | 893.11M | 904.43M | 919.32M | 926.39M | 938.65M | 952.98M | 968.30M | 976.73M | 996.31M |
| Weighted Average Shares Outstanding Diluted | 290.21M | 893.41M | 904.74M | 919.66M | 927.38M | 946.73M | 967.90M | 983.46M | 991.87M | 1.00B |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $358.09B | $309.22B | $254.42B | $276.17B | $208.86B | $193.55B | $140.11B | $107.85B | $80.23B | $50.78B |
| Short Term Investments | $- | $254.13B | $210.76B | $142.15B | $171.16B | $133.26B | $124.30B | $98.80B | $97.20B | $58.70B |
| Cash and Short Term Investments | $358.09B | $563.36B | $465.18B | $418.32B | $380.02B | $326.81B | $264.41B | $206.65B | $177.43B | $109.48B |
| Net Receivables | $122.83B | $109.78B | $122.97B | $- | $79.73B | $101.35B | $53.20B | $59.34B | $65.21B | $70.58B |
| Inventory | $64.92B | $57.92B | $45.89B | $38.00B | $33.82B | $40.11B | $34.63B | $41.39B | $42.18B | $44.48B |
| Other Current Assets | $238.37B | $307.27B | $235.93B | $164.09B | $193.62B | $124.49B | $39.02B | $36.02B | $30.79B | $35.40B |
| Total Current Assets | $784.21B | $784.19B | $659.21B | $556.24B | $516.03B | $461.74B | $391.27B | $343.38B | $315.61B | $259.95B |
| Property Plant Equipment Net | $124.03B | $118.57B | $112.42B | $95.71B | $76.01B | $74.65B | $75.96B | $78.79B | $78.67B | $77.02B |
| Goodwill | $15.29B | $9.82B | $9.64B | $9.36B | $10.85B | $19.26B | $32.85B | $37.63B | $41.21B | $46.53B |
| Intangible Assets | $117.62B | $96.31B | $81.22B | $76.56B | $46.54B | $35.51B | $42.21B | $53.49B | $30.42B | $33.79B |
| Goodwill and Intangible Assets | $132.91B | $106.13B | $90.86B | $85.92B | $57.39B | $54.77B | $75.06B | $91.12B | $71.63B | $80.33B |
| Long Term Investments | $320.09B | $280.81B | $275.21B | $249.40B | $219.05B | $185.78B | $31.38B | $37.17B | $49.25B | $99.64B |
| Tax Assets | $13.53B | $22.10B | $12.91B | $11.73B | $3.05B | $1.79B | $146.03B | $117.21B | $5.16B | $7.19B |
| Other Non-Current Assets | $42.16B | $3.00M | $5.00M | $4.00M | $4.00M | $-2.00M | $2.81B | $2.60B | $119.31B | $78.77B |
| Total Non-Current Assets | $632.71B | $527.61B | $491.40B | $442.75B | $355.50B | $316.99B | $331.23B | $326.88B | $324.02B | $342.95B |
| Other Assets | $- | $1.00M | $- | $- | $- | $4.00M | $2.00M | $2.00M | $4.00M | $4.00M |
| Total Assets | $1.42T | $1.31T | $1.15T | $998.99B | $871.53B | $778.74B | $722.50B | $670.27B | $639.64B | $602.90B |
| Account Payables | $14.81B | $14.01B | $16.37B | $9.90B | $10.76B | $9.44B | $8.02B | $11.94B | $11.05B | $11.57B |
| Short Term Debt | $2.87B | $3.01B | $2.94B | $3.38B | $6.72B | $918.00M | $10.00B | $- | $- | $38.00M |
| Tax Payables | $20.84B | $42.22B | $17.97B | $28.03B | $21.89B | $35.87B | $19.51B | $28.75B | $20.29B | $16.45B |
| Deferred Revenue | $- | $71.94B | $40.00B | $49.42B | $39.44B | $46.52B | $29.72B | $-289.00M | $-262.00M | $27.68B |
| Other Current Liabilities | $95.39B | $27.38B | $47.11B | $9.45B | $41.75B | $49.92B | $41.51B | $49.91B | $40.64B | $39.74B |
| Total Current Liabilities | $133.91B | $158.55B | $124.40B | $100.18B | $81.12B | $89.11B | $72.57B | $90.59B | $71.98B | $67.79B |
| Long Term Debt | $8.75B | $6.40B | $3.73B | $4.61B | $4.79B | $- | $18.49B | $30.05B | $30.07B | $30.09B |
| Deferred Revenue Non-Current | $- | $17.71B | $21.03B | $21.56B | $20.27B | $- | $8.10B | $9.58B | $9.45B | $9.90B |
| Deferred Tax Liabilities Non-Current | $4.36B | $5.92B | $7.81B | $7.75B | $373.00M | $124.00M | $14.16B | $9.37B | $12.86B | $14.54B |
| Other Non-Current Liabilities | $17.34B | $1.35B | $356.00M | $345.00M | $21.00B | $17.08B | $26.60B | $4.46B | $1.40B | $1.69B |
| Total Non-Current Liabilities | $30.45B | $31.37B | $32.92B | $34.26B | $25.80B | $17.21B | $45.09B | $53.47B | $53.78B | $56.22B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $164.36B | $189.92B | $157.32B | $134.44B | $106.92B | $106.31B | $117.66B | $144.06B | $125.76B | $124.02B |
| Preferred Stock | $- | $914.02B | $810.84B | $729.27B | $672.71B | $486.41B | $- | $- | $- | $- |
| Common Stock | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B | $21.28B |
| Retained Earnings | $1.07T | $940.61B | $832.96B | $752.25B | $708.29B | $639.46B | $574.39B | $508.05B | $503.95B | $455.50B |
| Accumulated Other Comprehensive Income Loss | $271.78B | $186.03B | $164.82B | $116.84B | $91.85B | $181.62B | $22.12B | $291.00M | $14.10B | $27.28B |
| Other Total Stockholders Equity | $-123.64B | $-47.87B | $-43.40B | $-44.26B | $-1.49T | $-148.35B | $112.77B | $-6.88B | $-29.53B | $-29.53B |
| Total Stockholders Equity | $1.24T | $1.10T | $975.66B | $846.11B | $764.56B | $668.03B | $601.37B | $522.74B | $509.79B | $474.53B |
| Total Equity | $1.25T | $1.12T | $993.28B | $864.55B | $764.61B | $672.43B | $604.84B | $526.21B | $513.88B | $478.88B |
| Total Liabilities and Stockholders Equity | $1.42T | $1.31T | $1.15T | $998.99B | $871.53B | $778.74B | $722.50B | $670.27B | $639.64B | $602.90B |
| Minority Interest | $17.24B | $21.83B | $17.62B | $18.44B | $51.00M | $4.40B | $3.47B | $3.47B | $4.08B | $4.35B |
| Total Liabilities and Total Equity | $1.42T | $1.31T | $1.15T | $998.99B | $871.53B | $778.74B | $722.50B | $670.27B | $639.64B | $602.90B |
| Total Investments | $320.09B | $247.71B | $242.48B | $217.44B | $202.16B | $151.85B | $155.68B | $135.97B | $146.45B | $158.34B |
| Total Debt | $11.62B | $9.41B | $6.67B | $7.99B | $8.15B | $920.00M | $28.49B | $30.05B | $30.07B | $30.13B |
| Net Debt | $-346.47B | $-299.81B | $-247.75B | $-268.19B | $-200.71B | $-192.63B | $-111.61B | $-77.79B | $-50.16B | $-20.65B |
Cash Flow Statement
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $162.03B | $220.33B | $126.27B | $143.02B | $158.52B | $170.34B | $137.38B | $122.69B | $97.45B | $82.05B |
| Depreciation and Amortization | $18.32B | $17.16B | $16.35B | $14.78B | $14.12B | $19.20B | $19.01B | $16.34B | $15.87B | $15.65B |
| Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Change in Working Capital | $-5.42B | $9.98B | $-38.86B | $-2.82B | $16.78B | $-11.77B | $7.88B | $11.37B | $8.07B | $-1.83B |
| Accounts Receivables | $-12.37B | $13.94B | $-43.42B | $2.99B | $21.37B | $-12.43B | $5.97B | $5.80B | $5.20B | $-5.75B |
| Inventory | $-6.34B | $-11.70B | $-7.13B | $-3.44B | $1.16B | $-4.83B | $6.55B | $625.00M | $1.94B | $4.70B |
| Accounts Payables | $-5.82B | $7.74B | $11.69B | $-2.38B | $-5.75B | $4.92B | $-3.81B | $893.00M | $760.00M | $- |
| Other Working Capital | $19.10B | $-32.24B | $15.09B | $-16.52B | $-9.20B | $568.00M | $1.32B | $10.74B | $6.13B | $-6.53B |
| Other Non Cash Items | $-20.65B | $-69.61B | $-1.69B | $-45.94B | $-57.47B | $-32.09B | $-34.47B | $-38.50B | $-19.10B | $-50.27B |
| Net Cash Provided by Operating Activities | $154.28B | $177.87B | $102.07B | $109.04B | $131.94B | $145.68B | $129.79B | $111.90B | $102.29B | $45.60B |
| Investments in Property Plant and Equipment | $-28.27B | $-37.19B | $-31.56B | $-32.94B | $-11.77B | $-9.12B | $-17.01B | $-23.26B | $-15.10B | $-13.38B |
| Acquisitions Net | $-27.50B | $-25.33B | $-5.38B | $-3.64B | $-8.78B | $-6.68B | $-11.02B | $-12.80B | $-543.00M | $211.00M |
| Purchases of Investments | $-295.96B | $-482.27B | $-399.78B | $-350.95B | $-300.46B | $-135.61B | $-118.66B | $-54.64B | $-71.53B | $-48.25B |
| Sales Maturities of Investments | $349.39B | $467.86B | $334.20B | $385.96B | $294.16B | $111.79B | $84.56B | $45.84B | $54.24B | $21.75B |
| Other Investing Activities | $8.26B | $28.64B | $6.32B | $-3.70B | $-2.30B | $3.28B | $10.89B | $13.22B | $44.00M | $7.97B |
| Net Cash Used for Investing Activities | $5.92B | $-48.29B | $-96.20B | $-5.26B | $-29.14B | $-36.35B | $-51.24B | $-31.64B | $-32.89B | $-31.70B |
| Debt Repayment | $- | $- | $- | $- | $- | $-10.00B | $- | $- | $-38.00M | $70.00M |
| Common Stock Issued | $- | $- | $- | $33.53B | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-75.18B | $-49.54B | $-14.00M | $-50.13B | $-50.16B | $-50.27B | $-29.37B | $-35.01B | $-25.00M | $-30.05B |
| Dividends Paid | $-43.88B | $-36.14B | $-33.15B | $-32.53B | $-31.12B | $-27.64B | $-24.23B | $-22.11B | $-18.22B | $-16.06B |
| Other Financing Activities | $-7.79B | $1.56B | $-3.46B | $5.24B | $-6.89B | $898.00M | $-289.00M | $-285.00M | $-246.00M | $-171.00M |
| Net Cash Used Provided by Financing Activities | $-126.85B | $-84.12B | $-36.62B | $-43.89B | $-88.17B | $-87.01B | $-53.89B | $-57.41B | $-18.52B | $-46.21B |
| Effect of Forex Changes on Cash | $15.51B | $9.35B | $9.00B | $7.42B | $-1.56B | $1.08B | $-1.58B | $-1.27B | $-1.85B | $2.69B |
| Net Change in Cash | $48.87B | $54.80B | $-21.75B | $67.31B | $13.06B | $23.40B | $23.08B | $21.58B | $49.02B | $-29.62B |
| Cash at End of Period | $358.09B | $309.22B | $254.42B | $276.17B | $208.86B | $195.80B | $172.40B | $149.32B | $127.74B | $78.72B |
| Cash at Beginning of Period | $309.22B | $254.42B | $276.17B | $208.86B | $195.80B | $172.40B | $149.32B | $127.74B | $78.72B | $108.34B |
| Operating Cash Flow | $154.28B | $177.87B | $102.07B | $109.04B | $131.94B | $145.68B | $129.79B | $111.90B | $102.29B | $45.60B |
| Capital Expenditure | $-28.27B | $-37.19B | $-31.56B | $-32.94B | $-11.77B | $-9.12B | $-17.01B | $-23.26B | $-15.10B | $-13.38B |
| Free Cash Flow | $126.02B | $140.68B | $70.50B | $76.09B | $120.17B | $136.56B | $112.78B | $88.64B | $87.19B | $32.23B |